Engineered E. coli Enhances Tumor Immunotherapy via NO
In a groundbreaking advancement at the intersection of microbiology and cancer immunotherapy, researchers have engineered a strain of Escherichia coli ...
In a groundbreaking advancement at the intersection of microbiology and cancer immunotherapy, researchers have engineered a strain of Escherichia coli ...
A groundbreaking development in immunotherapy from UCLA scientists has unveiled a next-generation chimeric antigen receptor T-cell (CAR-T) therapy engineered to ...
Cancer immunotherapy has revolutionized the treatment landscape for several malignancies by harnessing the patient’s own immune system to identify and ...
In a groundbreaking advancement in ovarian cancer therapeutics, researchers have unveiled a pioneering gene immunotherapy approach leveraging adeno-associated virus (AAV) ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine